Literature DB >> 9824304

Cloning of murine low molecular weight phosphotyrosine protein phosphatase cDNA: identification of a new isoform.

F Magherini1, E Giannoni, G Raugei, P Cirri, P Paoli, A Modesti, G Camici, G Ramponi.   

Abstract

The low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) is a 18 kDa cytosolic enzyme, involved in the negative regulation of cell proliferation. In different mammalian species LMW-PTPs are expressed in two molecular forms produced from a single primary transcript through an alternative splicing mechanism. In this paper we report the cloning, expression and characterization of mouse isoforms of LMW-PTPs (called m-IF1 and m-IF2), very similar to the corresponding rat and human isoenzymes. Moreover we have identified a third cDNA encoding a protein (m-IF2P) that presents three substitutions compared to m-IF2. This new isoform is still active on pNPP, although to a lower extent: this reduction is mainly due to the leucine to proline substitution in position 13, within the catalytic loop. The mRNA expression level of this isoform is comparable to those of m-IF1 and m-IF2. It is likely that a gene duplication process followed by mutations has generated this new gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824304     DOI: 10.1016/s0014-5793(98)01241-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Low-molecular-weight protein tyrosine phosphatase is a positive component of the fibroblast growth factor receptor signaling pathway.

Authors:  Eui Kyun Park; Neil Warner; Kathleen Mood; Tony Pawson; Ira O Daar
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

2.  Identification of protein-ribulosamine-5-phosphatase as human low-molecular-mass protein tyrosine phosphatase-A.

Authors:  Juliette Fortpied; Rita Gemayel; Didier Vertommen; Emile Van Schaftingen
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

3.  Discovery of Orally Bioavailable Purine-Based Inhibitors of the Low-Molecular-Weight Protein Tyrosine Phosphatase.

Authors:  Stephanie M Stanford; Michael A Diaz; Robert J Ardecky; Jiwen Zou; Tarmo Roosild; Zachary J Holmes; Tiffany P Nguyen; Michael P Hedrick; Socorro Rodiles; April Guan; Stefan Grotegut; Eugenio Santelli; Thomas D Y Chung; Michael R Jackson; Nunzio Bottini; Anthony B Pinkerton
Journal:  J Med Chem       Date:  2021-04-29       Impact factor: 7.446

4.  Deletion of low molecular weight protein tyrosine phosphatase (Acp1) protects against stress-induced cardiomyopathy.

Authors:  Fallou Wade; Pearl Quijada; Kamar Mohamed Adib Al-Haffar; Salma Mahmoud Awad; Muhammad Kunhi; Haruhiro Toko; Qussay Marashly; Karim Belhaj; Israa Zahid; Falah Al-Mohanna; Stephanie M Stanford; Roberto Alvarez; Yingge Liu; Dilek Colak; Maria C Jordan; Kenneth P Roos; Abdullah Assiri; Waleed Al-Habeeb; Mark Sussman; Nunzio Bottini; Coralie Poizat
Journal:  J Pathol       Date:  2015-09-01       Impact factor: 7.996

Review 5.  Protein tyrosine phosphatases in cardiac physiology and pathophysiology.

Authors:  Fallou Wade; Karim Belhaj; Coralie Poizat
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.